India to Italy: Mycophenolate Export Trade Route
India has recorded 122 verified shipments of Mycophenolate exported to Italy, representing a combined trade value of $4.4M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $36.1K USD. The leading Indian exporter is EMCURE PHARMACEUTICALS LIMITED, which accounts for 71% of total export value with 47 shipments worth $3.1M USD. On the buying side, TILLOMED ITALIA SRL is the largest importer in Italy with $2.8M USD in purchases. The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Italy Mycophenolate corridor is one of India's established pharmaceutical export routes, with 122 shipments documented worth a combined $4.4M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's mycophenolate manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $36.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with mycophenolate's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #10 among India's top mycophenolate export destinations globally.
On the import side, key buyers of Indian mycophenolate in Italy include TILLOMED ITALIA SRL, TILLOMED ITALIA SRL , TO THE ORDER and 14 others. TILLOMED ITALIA SRL is the single largest importer with 40 shipments valued at $2.8M USD.
